Found: 15
Select item for more details and to access through your institution.
Anticholinergic exposure and its association with dementia/Alzheimer's disease and mortality in older adults.
- Published in:
- BMC Geriatrics, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12877-023-04095-7
- By:
- Publication type:
- Article
Impact of Coexisting Overactive Bladder in Medicare Patients With Dementia on Clinical and Economic Outcomes.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2019, v. 34, n. 7/8, p. 492, doi. 10.1177/1533317519841164
- By:
- Publication type:
- Article
A prospective study of elderly initiating mirabegron versus antimuscarinics: Patient reported outcomes from the Overactive Bladder Satisfaction Scales and other instruments.
- Published in:
- Neurourology & Urodynamics, 2018, v. 37, n. 1, p. 177, doi. 10.1002/nau.23271
- By:
- Publication type:
- Article
A Historical Retrospective Analysis of the Impact of Diabetes Quality Measure Attainment on Outcomes in Medicare Advantage Members.
- Published in:
- Population Health Management, 2017, v. 20, n. 2, p. 146, doi. 10.1089/pop.2015.0159
- By:
- Publication type:
- Article
A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.
- Published in:
- BMC Health Services Research, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12913-015-0829-9
- By:
- Publication type:
- Article
Impact of a Pregabalin Step Therapy Policy Among Medicare Advantage Beneficiaries.
- Published in:
- Pain Practice, 2014, v. 14, n. 5, p. 419, doi. 10.1111/papr.12073
- By:
- Publication type:
- Article
Heart Failure Among Patients with Multiple Myeloma Treated with Carfilzomib-Based Versus Non-Carfilzomib-Based Regimens in the United States by Race.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 8, p. 616, doi. 10.1016/j.clml.2023.04.009
- By:
- Publication type:
- Article
The Clinical and Economic Burden of Newly Diagnosed Alzheimer’s Disease in a Medicare Advantage Population.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The Clinical and Economic Burden of Newly Diagnosed Alzheimer’s Disease in a Medicare Advantage Population.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2013, v. 28, n. 4, p. 384, doi. 10.1177/1533317513488911
- By:
- Publication type:
- Article
The Relationship Between Anticholinergic Exposure and Falls, Fractures, and Mortality in Patients with Overactive Bladder.
- Published in:
- Drugs & Aging, 2019, v. 36, n. 10, p. 957, doi. 10.1007/s40266-019-00694-5
- By:
- Publication type:
- Article
Effect of Potentially Inappropriate Use of Antimuscarinic Medications on Healthcare Use and Cost in Individuals with Overactive Bladder.
- Published in:
- Journal of the American Geriatrics Society, 2016, v. 64, n. 4, p. 779, doi. 10.1111/jgs.14030
- By:
- Publication type:
- Article
Household Members of Persons with Alzheimer's Disease: Health Conditions, Healthcare Resource Use, and Healthcare Costs.
- Published in:
- Journal of the American Geriatrics Society, 2014, v. 62, n. 3, p. 435, doi. 10.1111/jgs.12694
- By:
- Publication type:
- Article
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Erratum to: A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.
- Published in:
- 2015
- By:
- Publication type:
- corrected article